Eng C - Search Results

1

Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing.

Syngal S, Fox EA, Li C, Dovidio M, Eng C, Kolodner RD, Garber JE. Syngal S, et al. Among authors: eng c. JAMA. 1999 Jul 21;282(3):247-53. doi: 10.1001/jama.282.3.247. JAMA. 1999. PMID: 10422993

2

Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.

Nilsson O, Tisell LE, Jansson S, Ahlman H, Gimm O, Eng C. Nilsson O, et al. Among authors: eng c. JAMA. 1999 May 5;281(17):1587-8. doi: 10.1001/jama.281.17.1587. JAMA. 1999. PMID: 10235148 No abstract available.

3

Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.

Marsh DJ, Dahia PL, Coulon V, Zheng Z, Dorion-Bonnet F, Call KM, Little R, Lin AY, Eeles RA, Goldstein AM, Hodgson SV, Richardson AL, Robinson BG, Weber HC, Longy M, Eng C. Marsh DJ, et al. Among authors: eng c. Genes Chromosomes Cancer. 1998 Jan;21(1):61-9. doi: 10.1002/(sici)1098-2264(199801)21:1<61::aid-gcc8>3.0.co;2-6. Genes Chromosomes Cancer. 1998. PMID: 9443042

4

Mutation analysis of glial cell line-derived neurotrophic factor (GDNF), a ligand for the RET/GDNF receptor alpha complex, in sporadic phaeochromocytomas.

Dahia PL, Toledo SP, Mulligan LM, Maher ER, Grossman AB, Eng C. Dahia PL, et al. Among authors: eng c. Cancer Res. 1997 Jan 15;57(2):310-3. Cancer Res. 1997. PMID: 9000574

5

RET proto-oncogene in the development of human cancer.

Eng C. Eng C. J Clin Oncol. 1999 Jan;17(1):380-93. doi: 10.1200/JCO.1999.17.1.380. J Clin Oncol. 1999. PMID: 10458257 Review.

6

Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.

Marsh DJ, Zheng Z, Arnold A, Andrew SD, Learoyd D, Frilling A, Komminoth P, Neumann HP, Ponder BA, Rollins BJ, Shapiro GI, Robinson BG, Mulligan LM, Eng C. Marsh DJ, et al. Among authors: eng c. J Clin Endocrinol Metab. 1997 Sep;82(9):3025-8. doi: 10.1210/jcem.82.9.4197. J Clin Endocrinol Metab. 1997. PMID: 9284737

7

RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.

Marsh DJ, Mulligan LM, Eng C. Marsh DJ, et al. Among authors: eng c. Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461. Horm Res. 1997. PMID: 9167949 Review.

8

Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.

Eng C, Mulligan LM. Eng C, et al. Hum Mutat. 1997;9(2):97-109. doi: 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M. Hum Mutat. 1997. PMID: 9067749 Review.

9

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI, Marsh DJ, Robinson BG, Frank-Raue K, Raue F, Xue F, Noll WW, Romei C, Pacini F, Fink M, Niederle B, Zedenius J, Nordenskjöld M, Komminoth P, Hendy GN, Mulligan LM, et al. Eng C, et al. JAMA. 1996 Nov 20;276(19):1575-9. JAMA. 1996. PMID: 8918855

10

Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.

Neumann HP, Eng C, Mulligan LM, Glavac D, Zäuner I, Ponder BA, Crossey PA, Maher ER, Brauch H. Neumann HP, et al. Among authors: eng c. JAMA. 1995 Oct 11;274(14):1149-51. JAMA. 1995. PMID: 7563486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results